MML Investors Services
LENZ

MML Investors Services’s LENZ Therapeutics LENZ Stock Holding History

MML Investors Services’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$114K Buy
+20,043
New +$162K ﹤0.01% 3183

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

MML Investors Services's LENZ Position: Q2 2026 in Review

MML Investors Services opened a new position in LENZ Therapeutics (LENZ) in Q2 2026: 20,043 shares worth $114K. The stake represents ﹤0.01% of the portfolio and ranks #3183 among its holdings.

144 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • MML Investors Services held 20,043 shares of LENZ Therapeutics worth $114K as of Q2 2026.
  • LENZ Therapeutics was a new MML Investors Services position in Q2 2026.
  • LENZ Therapeutics made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #3183 holding.
  • 144 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.